Prazosin Market Share 2022: Trends, Key Players, Industry Analysis and Forecast 2022-2028
The global prazosin market is estimated
to exhibit a negative CAGR of around 2% during the forecast period. Though the
rise in CVDs due to high BP, increasing patient pool, and increasing awareness
toward mental care are some of the positive factors for the growth of the
market. However, due to the presence of alternative drugs, discontinuation of
prazosin manufacturing by companies in the last decade, unfavorable
reimbursement policies for the branded drug in medical insurance, and side
effects associated with the drugs, the market is expected to show a negative
growth rate during the forecast period.
To learn more about this report request a sample
copy @ https://www.omrglobal.com/request-sample/prazosin-market
The global prazosin market is segmented
on the basis of its application into cardiovascular disease, neurological
syndromes, prostate disorders, and kidney disorders. It is majorly used for
cardiovascular disease that is used to relieve hypertension/high BP due to
which it will hold the largest market share.
Geographically, the study of the global
prazosin market covers the analysis of four major regions including North
America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and
Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific),
and the Rest of the World. North America is expected to hold the largest market
share during the forecast period. The high cost of drugs, significant sale of
branded drugs of Pfizer in the region is major factors for the largest market,
globally. In October 2018, Novitium Pharma LLC received the US FDA approval for
its Prazosin Hydrochloride Capsules USP which is also providing significant
market share in the region.
The companies which are contributing to
the growth of the global prazosin market include Pfizer Inc., Mylan N.V., Merk
KGaA, Teva Pharmaceuticals Industries Ltd., Apotex Inc., and others. The market
players are considerably contributing to the market growth by adopting various
strategies including new product launch, merger, and acquisition to stay
competitive in the market. In November 2019, Pfizer Inc., and Mylan NV
announced to form a new company named Viatris by merging Mylan and Upjohn
division of Pfizer. The deals were expected to be closed by mid of 2020,
however, due to the COVID-19 pandemic, the deal is expected to close by the end
of 2020.
Global Prazosin Market- Segmentation
By
Application
·
Cardiovascular Disease(CVD)
·
Neurological Syndromes
·
Prostate Disorders
·
Kidney Disorders
A full report of Global Prazosin Market is
available at: https://www.omrglobal.com/industry-reports/prazosin-market
Global Prazosin Market– Segment by Region
North America
·
United States
·
Canada
Europe
·
Germany
·
United Kingdom
·
France
·
Spain
·
Italy
·
Rest of Europe
Asia-Pacific
·
China
·
Japan
·
India
·
Rest of
Asia-Pacific
Rest of the World
·
Middle East &
Africa
·
Latin America
Company Profiles
·
Ajinomoto Co., Inc.
·
Apotex Inc.
·
Axon Medchem LLC
·
Cayman Chemical Co.
·
Johnlee
Pharmaceuticals Pvt. Ltd.
·
Merck KGaA
·
NovitiumPharma
·
Pfizer Inc.
·
R&D Systems
Inc.
·
Renata Ltd.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more
than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and
after purchasing your report.
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
Media Contact:
Contact
Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no:
+91 780-304-0404
Company
Name: Orion Market Research
0 Comments